Listing & Compliance Notices

AI Transportation Acquisition Corp received a nasdaq delisting notice notice regarding other (rules 5250(f)).

“April 14, 2025, the Company received an additional notice from Nasdaq, which notified the Company that because of its failure to pay certain fees required by Listing Rule 5250(f), the Company will be delisted unless it appeals this determination. The Company does not intend to request a hearing before the panel to appeal the determination. Accordingly, the trading of the Company’s securities was suspended at the opening of business on April 16, 2025. Nasdaq intends to file a Form 25-NSE with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from lis”

AI Transportation Acquisition Corp received a nasdaq delisting notice notice regarding late filing (rules 5250(f)).

“April 11, 2025, AI Transportation Acquisition Corp. (“AITR” or the “Company”) received a notice (the “Notice”) from the Nasdaq Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company’s failure to file its Annual Report on Form 10-K for the year ended December 31, 2021 (the “Form 10-K”), serves a basis for delisting the Company’s securities from Nasdaq. On April 14, 2025, the Company received an additional notice from Nasdaq, which notified the Company that because of its failure to pay certain fees required by Listing Rule 5250(f), the Company will be de”

SUNation Energy, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv)).

“April 11, 2025 , the Company received a letter (the “Minimum Bid Price Deficiency Letter”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the 30 consecutive business day period immediately preceding deficiency letter, the Company’s common stock had not maintained a minimum closing bid price of $1.00 per share (the “Minimum Bid Price Requirement”) and, as a result, does not comply with Listing Rule 5550(a)(2) (the “Rule”). Normally, a company would be afforded a 180-calendar day period to demonstrate compliance with”

Carisma Therapeutics Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“January 6, 2025, Nasdaq notified the Company that it no longer satisfied Nasdaq Listing Rule 5450(a)(1), which requires the Company to maintain a minimum bid price of $1.00 per share (the “Bid Price Rule” together with the MVLS Rule and the MVPHS Rule, the “Price-based Rules”) for continued listing on The Nasdaq Global Market. In accordance with the Grace Period Rule Nasdaq granted the Company 180 calendar days, through July 7, 2025, to regain compliance with the Bid Price Rule. To evidence compliance with the Price-based Rules, an issuer must evidence compliance with the applicable minimum th”

Carisma Therapeutics Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).

“g is held and any extension that the Panel may grant to the Company following the hearing has expired. There can be no assurance that the Panel will grant the Company’s request for continued listing. Also on April 10, 2025, Nasdaq notified the Company that it no longer satisfied Nasdaq Listing Rule 5450(b)(2)(C), which requires the Company to maintain a minimum market value of publicly held shares (“MVPHS”) of $15.0 million (the “MVPHS Rule”) for continued listing on The Nasdaq Global Market. In accordance with the Grace Period Rule, Nasdaq provided the Company 180 calendar days, or until Octo”

Carisma Therapeutics Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“g is held and any extension that the Panel may grant to the Company following the hearing has expired. There can be no assurance that the Panel will grant the Company’s request for continued listing. Also on April 10, 2025, Nasdaq notified the Company that it no longer satisfied Nasdaq Listing Rule 5450(b)(2)(C), which requires the Company to maintain a minimum market value of publicly held shares (“MVPHS”) of $15.0 million (the “MVPHS Rule”) for continued listing on The Nasdaq Global Market. In accordance with the Grace Period Rule, Nasdaq provided the Company 180 calendar days, or until Octo”

Beeline Holdings, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“April 15, 2025, Beeline Holdings, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company of its compliance with Nasdaq Listing Rule 5550(a)(2) (the “Rule”) by maintaining a minimum bid price for its common stock of at least $1.00 for the last 25 consecutive business days, from March 12, 2025 to April 14, 2025. Accordingly, the Company has regained compliance with the Rule and the matter is now closed.”

LeonaBio, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“October 16, 2024 notifying the Company that, based on the closing bid price of the Company’s Common Stock, for the preceding 30 consecutive business days, the Company was not in compliance with the minimum bid price requirement for continued listing on The Nasdaq Global Select Market. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company had an initial compliance period of 180 calendar days, or until April 14, 2025, to regain compliance with t”

SCWorx Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 10, 2025, Nasdaq notified the Company that based upon the Company’s closing bid price for the last 30 consecutive business days (February 26, 2025 through April 9, 2025), the Company no longer meets the listed securities requirement to maintain a minimum bid price of $1 per share pursuant to Nasdaq Rules 5550(a)(2) and 5810(c)(3)(A). However, the Nasdaq Rules provide a compliance period of 180 calendar days, through October 7, 2025, in which to regain compliance. Nasdaq has advised us that, under the Nasdaq Rules, if at any time during this 180 day period the closing bid price of the Com”

Hall of Fame Resort & Entertainment Co received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5810(c)(3)(H)).

“April 10, 2025, Hall of Fame Resort & Entertainment Company (the “Company”) received a deficiency letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s common stock (the “Common Stock”) had closed below $1.00 per share, which is the minimum bid price required to maintain continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”). The Notice has no immediate effect on the”

Offerpad Solutions Inc. received a nyse deficiency notice notice regarding market value (rules 802.01B).

“April 10, 2025, Offerpad Solutions Inc. (the “Company”) received written notice (the “NYSE Notification”) from the New York Stock Exchange (the “NYSE”) that the Company is not in compliance with Section 802.01B of the NYSE Listed Company Manual because the average global market capitalization of the Company over a consecutive 30 trading-day period and, at the same time, the Company’s last reported stockholders’ equity were each less than $50 million. The Company plans to notify the NYSE that it intends to submit a plan to cure the deficiency and to return to compliance with the NYSE continued”

Solidion Technology Inc. received a nasdaq noncompliance notice notice regarding other (rules 5450(b)(3)(A)).

“April 10, 2025, Solidion Technology, Inc. (the “ Company ”) received notice (the “ Notice ”) from the Listing Qualifications staff of the Nasdaq Stock Market LLC (“ Nasdaq ”) due to the Company’s noncompliance with Nasdaq Listing Rules 5450(b)(2)(A) and 5450(b)(3)(A). The Notice cites the Company’s (a) not being in compliance with the minimum Market Value of Listed Securities (“ MVLS ”) requirement as set forth in Nasdaq Listing Rule 5450(b)(2)(A) and (b) not being in compliance with the total assets and total revenue standard as set forth in Nasdaq Listing Rule 5450(b)(3)(A) (collectively, th”

Solidion Technology Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5450(b)(3)(A)).

“April 10, 2025, Solidion Technology, Inc. (the “ Company ”) received notice (the “ Notice ”) from the Listing Qualifications staff of the Nasdaq Stock Market LLC (“ Nasdaq ”) due to the Company’s noncompliance with Nasdaq Listing Rules 5450(b)(2)(A) and 5450(b)(3)(A). The Notice cites the Company’s (a) not being in compliance with the minimum Market Value of Listed Securities (“ MVLS ”) requirement as set forth in Nasdaq Listing Rule 5450(b)(2)(A) and (b) not being in compliance with the total assets and total revenue standard as set forth in Nasdaq Listing Rule 5450(b)(3)(A) (collectively, th”

Abpro Holdings, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“April 10, 2025, Abpro Holdings, Inc. (the “Company”) received two letters from the listing qualifications department staff (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”). One letter (the “MVPHS Notice”) indicated that based upon Nasdaq’s review of the Company’s Market Value of Publicly Held Shares (“MVPHS”) for the last 30 consecutive business days prior to the date of the MVPHS Notice, the Company no longer meets the requirements of Nasdaq Listing Rule 5450(b)(2)(C), which requires listed securities to maintain a minimum MVPHS of $15,000,000 (the “MVPHS Requirement”). The Company intends”

Abpro Holdings, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).

“April 10, 2025, Abpro Holdings, Inc. (the “Company”) received two letters from the listing qualifications department staff (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”). One letter (the “MVPHS Notice”) indicated that based upon Nasdaq’s review of the Company’s Market Value of Publicly Held Shares (“MVPHS”) for the last 30 consecutive business days prior to the date of the MVPHS Notice, the Company no longer meets the requirements of Nasdaq Listing Rule 5450(b)(2)(C), which requires listed securities to maintain a minimum MVPHS of $15,000,000 (the “MVPHS Requirement”). The Company intends”

Aspira Women's Health Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 15, 2025, Aspira Women’s Health Inc. (the “Company) received written notice (the “Notice”) from the Office of General Counsel of The Nasdaq Stock Market (“Nasdaq”) indicating that the Nasdaq Hearings Panel has determined to delist the Company’s shares from Nasdaq due to the Company’s failure to meet Nasdaq’s continued listing standards. As previously disclosed, the Company has not been compliant with the requirements under Nasdaq Listing Rule 5550(b)(1) to maintain a minimum of $2.5 million in stockholders’ equity for continued listing on the Nasdaq Capital Market. The Notice indicated t”

SemiLEDs Corp received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).

“the Company an extension through April 14, 2025. As reported in the Company’s Quarter Report on Form 10-Q, the Company’s total stockholders’ equity as of February 28, 2025 was $3.6 million. As of the date of this Current Report, the Company believes that it has regained compliance with the stockholders’ equity requirement. Nasdaq will continue to monitor the”

Streamex Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 11, 2025, BioSig Technologies, Inc. (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between February 27, 2025, through April 10, 2025, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be provided with a compliance period of 180 calenda”

Next Technology Holding Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 14, 2025, Next Technology Holding Inc. (the “Company”) received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), which indicated that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”), as the Company’s closing bid price for its common stock, par value $0 per share (“Common Stock”), was below $1.00 per share for the prior thirty (30) consecutive business days. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a 180-calendar day compliance period, or until October 13, 2025 (the “Complian”

Greenidge Generation Holdings Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“April 9, 2025, Greenidge Generation Holdings Inc. (the “Company”) received written notice (the “Notice”) from Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s Class A common stock had closed below $1.00 per share, which is the minimum bid price required to maintain continued listing on The Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Requirement”). The Notice has no immediate effect on the listing of the Company’s Class A common sto”

OneMedNet Corp received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 10, 2025, OneMedNet Corporation (the “Company”) received notice (the “Notice”) from the staff of the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company, based on the closing bid price of the Company’s common stock for the last 30 consecutive business days, is not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a pe”

Cycurion, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“April 11, 2025, the Company received two letters from the Nasdaq, each addressing a separate compliance deficiency under the Rules. The first letter notified of the deficiency with regard to Rule 5450(b)(2)(A) (the “Second Nasdaq Notice”), which requires a company, whose securities are listed on The Nasdaq Global Market under the “Market Value Standard”, to maintain a minimum Market Value of Listed Securities (an “MVLS”) of $50,000,000. The deficiency was caused by the Company’s MVLS having been below the minimum level for the prior 30 consecutive business days. Under Nasdaq Listing Rule 5810(”

Cycurion, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1)).

“y’s security is at least $1.00 for a minimum of ten consecutive business days, Nasdaq will provide written confirmation of compliance and this matter will be closed. In the event the Company does not regain compliance with the Rule, the Company may be eligible for additional time under Listing Rule 5810(c)(3)(A)(ii). The Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency”

Greenpro Capital Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 11, 2025, Greenpro Capital Corp. (the “Company”) received a letter (the “Notice”) from the Nasdaq Stock Market LLC (the “NASDAQ”) notifying the Company that it is not in compliance with the minimum bid price requirement as set forth under NASDAQ Listing Rule 5550(a)(2) for continued listing of its common stock on the NASDAQ. Listing Rule 5550(a)(2) requires the registrant to maintain a minimum bid price of $1.00 per share for its securities listed on the NASDAQ, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency conti”

GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 11, 2025, Entero Therapeutics, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market, under Listing Rule 5550(b)(1), because the Company’s stockholders’ equity of ($3,876,738) as reported in the Company’s Annual Report on Form 10-K for the period ended December 31, 2024 was below the required minimum of $2.5 million, and because, as of April 10, 2025 the C”

Cambium Networks Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“April 10, 2025, Cambium Networks Corporation (“Cambium” or the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s Ordinary Shares closed below the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”)”

SOCIETY PASS INCORPORATED. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(2)).

“April 9, 2025, the Panel issued a decision that granted the Company’s request to continue its listing on Nasdaq based on the information presented. The Panel has determined to grant the Company’s request for an exception until June 30, 2025 (the “Extension Period”). The compliance plan was conditioned on (i) the Company filing a Form 8-K describing the transactions undertaken by the Company to achieve compliance and demonstrate long-term compliance with the Equity Rule, and by providing an indication of its equity following those transactions; and (ii) the Company will evidence compliance with”

Motorsport Games Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).

“in the most recently completed fiscal year or in two of the three most recently completed fiscal years. As of December 31, 2024, the Company’s stockholders’ equity was $1,226,002. In accordance with Nasdaq rules, the Company had until January 6, 2025 to submit a plan to the Nasdaq Staff to regain compliance with the Stockholders’ Equity Requirement, which”

ClimateRock received a nasdaq delisting notice notice regarding other.

“April 8, 2025, ClimateRock (the "Company" or "ClimateRock") received written notice (the “Notice Letter”) from the Nasdaq Hearings Panel (the “Panel”) indicating that the Panel had determined to delist the Company’s securities from The Nasdaq Stock Market LLC (“Nasdaq”) and that trading in the Company’s securities would be suspended at the open of trading on April 10, 2025, due to the Company’s failure to comply with the terms of the Panel’s January 6, 2026 decision (the “Decision”). Pursuant to the Decision, amongst other things, the Company was required to complete its initial business combi”

Thunder Power Holdings, Inc. received a nasdaq deficiency notice notice regarding other (rules 5101).

“April 8, 2025, Thunder Power Holdings, Inc. (the “Company”) was notified by the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Staff believes the Company is a “public shell,” as that term is defined by Nasdaq under Nasdaq Listing Rule 5101, and will consider this matter in rendering a determination regarding the Company’s continued listing. The Company disagrees with the Staff’s conclusion. As previously disclosed, the Company has requested a hearing before the Nasdaq Hearings Panel (the “Panel”), and plans to address the issue at the hearing”

Alaunos Therapeutics, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 7, 2025, Alaunos Therapeutics, Inc., (the “Company”) received a notice (the “Notice”) from the Listing Qualifications staff of Nasdaq notifying the Company that the Company’s stockholders equity as reported in its Annual Report on Form 10-K for the period ended December 31, 2024 (the “2024 10-K”), did not satisfy the continued listing requirements under Nasdaq Listing Rule 5550(b)(1) for the Nasdaq Capital Market, which requires that a listed company’s stockholder equity be at least $2,500,000. In its 2024 10-K, the Company reported stockholders’ equity of $2,063,000, and, as a result, d”

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. received a nasdaq deficiency notice notice regarding other (rules 5608(b)(1), 5608(b)(2)).

“April 8, 2025, the Company received a letter from Nasdaq stating that because the Company failed to timely adopt the Policy as required by Listing Rule 5608(b)(1), and failed to disclose the Policy in its Form 10-K for the fiscal years ended December 31, 2023 or December 31, 2024 (prior to its amendment), the Company previously did not comply with Listing Rule 5608(b)(2). However, in the letter, Nasdaq further informed the Company that it is currently in compliance with Nasdaq Listing Rules, and the matter raised by Nasdaq in the letter is now closed.”

RYVYL Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 8, 2025, RYVYL Inc., a Nevada corporation (the “Company”), received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based on the Company’s stockholders’ equity of ($1,492,000) as of December 31, 2024, it is no longer in compliance with the minimum stockholders’ equity requirement of $2.5 million for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1 ). The Company has until May 23, 2025 to provide Nasdaq with a plan to regain compliance with the foregoing listing requirement. If the Company’s plan to re”

Bone Biologics Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 7, 2025, Bone Biologics Corporation (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days, the Company no longer meets Nasdaq Listing Rule 5550(a)(2), which requires listed companies to maintain a minimum bid price of at least $1 per share. Nasdaq Listing Rule 5810(c)(3)(A) provides a compliance period of 180 calendar days, or until October 6, 2025, in which to regain compliance with the minimum bid price req”

SPLASH BEVERAGE GROUP, INC. received a nyse_american delisting notice notice regarding stockholders equity (rules 1009(a), 1003(a)(i), 1003(a)(ii), 1003(a)(iii)).

“April 7, 2025. On April 7, 2025, Splash Beverage Group, Inc. (the “Company”), NYSE American LLC (“NYSE American”) publicly announced and provided a notice to the Company that NYSE Regulation has determined to commence proceedings to delist the Company’s Common Stock, par value $0.001 (the “Common Stock”) and publicly trading Warrants to purchase one share of Common Stock (the “Warrants,” together with the Common Stock, the “Securities”), from NYSE American. NYSE Regulation has determined that the Company is no longer suitable for listing pursuant to Section 1009(a) of the NYSE American Company”

Super League Enterprise, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“Stockholders’ Equity Requirement was based on the Company’s filing of its Annual Report on Form 10-K for the year ended December 31, 2024, reporting the stockholders’ equity of $170,000. Pursuant to the Letter, the Company has 45 calendar days from the date of the Letter to submit a plan to regain compliance and the Company intends to submit such a plan during”

Adicet Bio, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“April 7, 2025, Adicet Bio, Inc. (the “Company”) received a notice from the Listing Qualifications staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) that because the closing bid price for the Company’s common stock had fallen below $1.00 per share for 30 consecutive business days, the Company no longer complied with the minimum bid price requirement for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Rule”). The letter does not result in the immediate delisting of the Company’s Common Stock, and the Company’s Common Stock will conti”

CISO Global, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 8, 2025, we received a letter from the listing qualifications staff (the “Staff”) of Nasdaq providing notification that that we, as a company listed on the Nasdaq Capital Market, are required to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing per Listing Rule 5550(b)(1) (the “Listing Rule”). Our Annual Report on Form 10-K for the year ended December 31, 2024 reported stockholders’ equity of $1,149,064. Therefore, as of April 7, 2025, we did not meet the alternatives of market value of listed securities or net income from continuing operations, and we no lon”

Origin Materials, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 7, 2025, Origin Materials, Inc. ("Origin") received a letter from the Nasdaq Listing Qualifications Staff (the "Staff") of The Nasdaq Stock Market ("Nasdaq") notifying Origin that for the last 31 consecutive business days the bid price of Origin’s common stock had closed below $1.00 per share, the minimum closing bid price (the "Minimum Bid Price") required by the continued listing requirements of Nasdaq listing rule 5550(a)(2). The notification received has no immediate effect on the listing of Origin’s common stock on Nasdaq. In accordance with Nasdaq's listing rule 5810(c)(3)(A), Orig”

Vicarious Surgical Inc. received a nyse noncompliance notice notice regarding market value (rules 802.01B).

“April 10, 2025, Vicarious Surgical, Inc. (the “Company”) received a written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) indicating the Company is no longer in compliance with the NYSE’s continued listing standards set forth in Section 802.01B of the NYSE’s Listed Company Manual (the “Minimum Market Capitalization Standard”) due to the fact that the Company’s average global market capitalization over a consecutive 30 trading-day period was less than $50 million and, at the same time, its stockholders’ equity was less than $50 million. As described in the Notice, as of Ap”

Petros Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1), 5810(c)(3)(A)(iii)).

“April 8, 2025, the Nasdaq notified the Company that it did not comply with the $2.5 million minimum stockholders’ equity requirement, as set forth in Nasdaq Listing Rule 5550(b)(1). Pursuant to Nasdaq Listing Rule 5810(d), this deficiency now becomes an additional basis for delisting, and as such, the Company intends to address these concerns before a Nasdaq Hearings Panel. As a result of the Company’s hearing request pending appeal notice, all delisting actions have been stayed, pending a hearing before the Panel.”

FiscalNote Holdings, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“April 10, 2025, FiscalNote Holdings, Inc. (the “Company”) received notice from the New York Stock Exchange (the “NYSE”) stating that it has concluded that the Company is not in compliance with Rule 802.01C of the NYSE’s continued listing requirements (the “NYSE Notification”), since as of April 9, 2025, the 30-trading day average closing price of the Company’s shares of Class A common stock, par value $0.0001 per share (the “Common Stock”) had fallen below $1.00 per share over a consecutive 30 trading-day period. Within 10 business days of receipt of the NYSE Notification, the Company must not”

Beachbody Company, Inc. received a nyse deficiency notice notice regarding market value (rules 802.01B).

“April 10, 2025, The Beachbody Company, Inc. (the “Company”) received notice from the New York Stock Exchange (the “NYSE”) that it was not currently in compliance with the requirement of Section 802.01B of the New York Stock Exchange Listed Company Manual (the “NYSE Manual”) that the Company have an average market capitalization of not less than $50.0 million over a consecutive 30 trading-day period and stockholders’ equity of not less than $50.0 million (the “NYSE Notice”). Pursuant to the NYSE Notice, the Company is subject to the procedures set forth in Sections 801 and 802 of the NYSE Manua”

Nuvve Holding Corp. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 7, 2025, Nuvve Holding Corp. (the “Company”), received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not currently in compliance with the requirement of maintaining stockholders’ equity of at least $2,500,000 for continued inclusion on The Nasdaq Capital Market under Nasdaq Marketplace Rule 5550(b)(1) (the “Stockholders’ Equity Rule”). In the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, the Company reported stockholders’ equity (deficit) of ($1,289,647), and”

EverCommerce Inc. received a nasdaq noncompliance notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)(B)).

“April 11, 2025, the Company notified Nasdaq of its non-compliance with Nasdaq Rule 5605(c)(2)(A) as a result of the Vacancy and its intent to rely on the cure period provided to the Company by Nasdaq Rule 5605(c)(4)(B). The Company intends to appoint to the Audit Committee a third director who satisfies the criteria for service on the Audit Committee no later than 180 days after the effectiveness of Ms. Wellman’s resignation.”

La Rosa Holdings Corp. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 9, 2025 (the “ Second Nasdaq Bid Price Letter ”), Nasdaq notified the Company that Nasdaq’s Staff has determined that the Company is eligible for an additional 180 calendar day period, or until October 6, 2025, to regain compliance (the “ Second Compliance Period ”). The determination is based on the Company’s meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on The Nasdaq Capital Market with the exception of the Bid Price Rule, and the Company’s written notice of its intention to cure the deficien”

MIRA PHARMACEUTICALS, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 8, 2025, MIRA Pharmaceuticals, Inc. (the “Company”) received a letter from the Nasdaq Listing Qualifications Staff indicating that, based on the Company’s stockholders’ equity of $2,199,750 as of December 31, 2024, the Company does not currently meet the minimum stockholders’ equity requirement of $2.5 million as set forth under Nasdaq Listing Rule 5550(b)(1). Importantly, this notice does not affect the Company’s listing status or the trading of its common stock, which will continue uninterrupted on the Nasdaq Capital Market under the ticker symbol “MIRA.” In accordance with Nasdaq proc”

HARVARD BIOSCIENCE INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“April 4, 2025, Harvard Bioscience, Inc. (the “Company”) received written notice (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5450(a)(1). Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the d”

FiEE, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 7, 2025, the Company received a second letter from the Staff (the “April 7, 2025 Letter”) stating that in addition to the failure to meet the Stockholders’ Equity Requirement, the Staff made additional determinations (the “Additional Deficiencies”) that the Company (1) failed to comply with the Nasdaq’s shareholder approval requirements pursuant to the Nasdaq Listing Rule 5635 (b), (c) and (d), in connection with the closing of transactions under that certain Amended and Restated Securities Purchase Agreement, dated February 18, 2025, attached as Exhibit 10.1 to the Company’s Current Rep”

Babcock & Wilcox Enterprises, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“April 4, 2025, Babcock & Wilcox Enterprises, Inc. (the “Company”) was notified by the New York Stock Exchange (the “NYSE”) that the average closing price of the Company’s common stock, par value $0.01 per share, over the prior consecutive 30 trading-day period was below $1.00, which is the minimum average closing price required to maintain listing on the NYSE under Section 802.01C of the NYSE Listed Company Manual (the “NYSE Notice”). Pursuant to Section 802.01C, the Company has a period of six months following receipt of the NYSE Notice to regain compliance with the minimum share price requir”